Indications and Outcome of Implantable Cardioverter‐Defibrillators for Primary and Secondary Prophylaxis in Patients with Noncompaction Cardiomyopathy

Abstract

In our cohort of NCCM patients, an ICD was frequently implanted for primary or secondary prevention of sudden cardiac death. At follow-up, frequent appropriate ICD therapy was observed in both groups, supporting the application of current ICD guidelines for primary and secondary prevention of sudden cardiac death in NCCM.